Stimulation of Bone Formation in Vitro and in Rodents by StatinsGregory R. Mundy, G. Gutierrez, R.J. Burriss Garrett et al.|Science|1999Cited by 1.8k
Current use of bisphosphonates in oncology. International Bone and Cancer Study Group.J.J. Body, R.D. Rubens, Reiner Bartl et al.|Journal of Clinical Oncology|1998Cited by 366
MEPE has the properties of an osteoblastic phosphatonin and minhibinPeter Rowe, Gregory R. Mundy, Russell Blacher et al.|Bone|2003Cited by 267
Statins and Bone Formation.I. Ross Garrett, Gregory R. Mundy, G. Gutierrez|Current Pharmaceutical Design|2001Cited by 187
Herbimycin A, a pp60c-src tyrosine kinase inhibitor, inhibits osteoclastic bone resorption in vitro and hypercalcemia in vivo.Toshiyuki Yoneda, Gregory R. Mundy, Carolyn Lowe et al.|Journal of Clinical Investigation|1993Cited by 89